{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:17:16Z","timestamp":1784297836328,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbrc.2021.08.052","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T05:13:41Z","timestamp":1630041221000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque"],"prefix":"10.1016","volume":"577","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2858-1172","authenticated-orcid":false,"given":"Konstantin","family":"Virnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-2507","authenticated-orcid":false,"given":"Wenshuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Medvedev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Perry-Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Majam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-8128","authenticated-orcid":false,"given":"Barbara K.","family":"Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-9354","authenticated-orcid":false,"given":"Sanjai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6337-3136","authenticated-orcid":false,"given":"Ira","family":"Berkower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.08.052_bib1","series-title":"World Malaria Report 2018","year":"2018"},{"key":"10.1016\/j.bbrc.2021.08.052_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.08.052_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria","volume":"6","author":"Hoffman","year":"2010","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib4","doi-asserted-by":"crossref","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","article-title":"Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein","volume":"114","author":"Oyen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2021.08.052_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A\u00a0human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2021.08.052_bib6","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2010.05.033","article-title":"The RTS,S malaria vaccine","volume":"28","author":"Casares","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.08.052_bib8","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS,S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"Bejon","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2021.08.052_bib9","article-title":"Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites","volume":"11","author":"RTS","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbrc.2021.08.052_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2021.08.052_bib11","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.08.052_bib12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa0807773","article-title":"Safety and immunogenicity of RTS,S\/AS02D malaria vaccine in infants","volume":"359","author":"Abdulla","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2021.08.052_bib13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial","volume":"366","author":"Alonso","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2021.08.052_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1207564","article-title":"Four-year efficacy of RTS,S\/AS01E and its interaction with malaria exposure","volume":"368","author":"Olotu","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2021.08.052_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.95.4.743","article-title":"Experimental rubella virus infection in the rhesus monkey","volume":"95","author":"Parkman","year":"1965","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2021.08.052_bib16","first-page":"688","article-title":"Rubella vaccine","author":"Plotkin","year":"2013","journal-title":"Vaccines, Saunders, Philadelphia"},{"key":"10.1016\/j.bbrc.2021.08.052_bib17","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.vaccine.2013.02.055","article-title":"Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions","volume":"31","author":"Virnik","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib18","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.vaccine.2017.04.047","article-title":"Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors","volume":"35","author":"Virnik","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib19","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4269\/ajtmh.18-0608","article-title":"Characteristics and severity of disease among 100 cases of imported malaria seen at a U.S. University hospital, 2000-2017","volume":"99","author":"Akselrod","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2021.08.052_bib20","doi-asserted-by":"crossref","first-page":"e8988","DOI":"10.1371\/journal.pone.0008988","article-title":"Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis","volume":"5","author":"Carneiro","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.08.052_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.gt.3302139","article-title":"Reduced immunogenicity of DNA vaccine plasmids in mixtures","volume":"11","author":"Sedegah","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2021.08.052_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jim.2013.02.001","article-title":"A\u00a0chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein","volume":"390","author":"Kumar","year":"2013","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.bbrc.2021.08.052_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-4690-10-99","article-title":"Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques","volume":"10","author":"Virnik","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.bbrc.2021.08.052_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/aid.1994.10.1651","article-title":"A\u00a0broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1","volume":"10","author":"Purtscher","year":"1994","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.bbrc.2021.08.052_bib25","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1074\/jbc.M112.436675","article-title":"The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production","volume":"288","author":"Jalah","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.08.052_bib26","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1016\/j.vaccine.2012.06.074","article-title":"Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers","volume":"30","author":"Virnik","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4049\/jimmunol.159.3.1362","article-title":"Binding of malaria T cell epitopes to DR and DQ molecules in\u00a0vitro correlates with immunogenicity in\u00a0vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein","volume":"159","author":"Calvo-Calle","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2021.08.052_bib28","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1128\/IAI.00356-07","article-title":"Jet\u00a0al. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy","volume":"75","author":"Chinchilla","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2021.08.052_bib29","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1016\/j.vaccine.2018.07.010","article-title":"Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost","volume":"36","author":"Virnik","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib30","article-title":"Diverse antibody responses to conserved structural motifs in plasmodium falciparum circumsporozoite protein","author":"Pholcharee","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2021.08.052_bib31","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2021.08.052_bib32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2007.12.018","article-title":"Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen","volume":"26","author":"Mettens","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-019-0106-8","article-title":"Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice","volume":"4","author":"Mura","year":"2019","journal-title":"NPJ Vaccine"},{"key":"10.1016\/j.bbrc.2021.08.052_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131571","article-title":"Ad35.CS.01-RTS,S\/AS01 heterologous prime boost vaccine efficacy against sporozoite challenge in healthy malaria-naive adults","volume":"10","author":"Ockenhouse","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.08.052_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024586","article-title":"Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults","volume":"6","author":"Sedegah","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.08.052_bib36","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.vaccine.2005.12.041","article-title":"A\u00a0clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S\/AS02A and MVA-CS","volume":"24","author":"Dunachie","year":"2006","journal-title":"Vaccine"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21012298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21012298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:41:40Z","timestamp":1762094500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21012298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"alternative-id":["S0006291X21012298"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.052","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}